PMC:7228307 / 42386-42656
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 716 | 87-94 | Gene | denotes | FcγRIII | Gene:2214 |
| 717 | 130-138 | Gene | denotes | FcγRIIIa | Gene:2214 |
| 721 | 198-205 | Species | denotes | patient | Tax:9606 |
| 723 | 263-269 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T70 | 263-269 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T762 | 87-89 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T763 | 112-114 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T764 | 130-132 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 716 | 87-94 | Gene | denotes | FcγRIII | Gene:2214 |
| 717 | 130-138 | Gene | denotes | FcγRIIIa | Gene:2214 |
| 721 | 198-205 | Species | denotes | patient | Tax:9606 |
| 723 | 263-269 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T239 | 0-270 | Sentence | denotes | Third, overcoming the significant affinity difference in the interaction with the main FcγRIII allelic forms of FcγRIIIa‐V158 and FcγRIIIa‐F158 76, 83, 84 which appears to be an important source of patient variability in responses to therapeutic mAb treatment of cancer. |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T26 | 263-269 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T16 | 263-269 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T239 | 0-270 | Sentence | denotes | Third, overcoming the significant affinity difference in the interaction with the main FcγRIII allelic forms of FcγRIIIa‐V158 and FcγRIIIa‐F158 76, 83, 84 which appears to be an important source of patient variability in responses to therapeutic mAb treatment of cancer. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T16 | 263-269 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |